R
Raquel de Oliveira Vilhena
Researcher at Federal University of Paraná
Publications - 25
Citations - 595
Raquel de Oliveira Vilhena is an academic researcher from Federal University of Paraná. The author has contributed to research in topics: Carbidopa & Entacapone. The author has an hindex of 7, co-authored 22 publications receiving 269 citations.
Papers
More filters
Journal ArticleDOI
Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19.
Beatriz Böger,Mariana Millan Fachi,Raquel de Oliveira Vilhena,Alexandre de Fátima Cobre,Fernanda S. Tonin,Roberto Pontarolo +5 more
TL;DR: RT-PCR remains the gold standard for the diagnosis of COVID-19 in sputum samples and the combination of different diagnostic tests is highly recommended to achieve adequate sensitivity and specificity.
Journal ArticleDOI
Occurrence of antibiotics and antibiotic resistant bacteria in subtropical urban rivers in Brazil
Beatriz Böger,Monica Surek,Raquel de Oliveira Vilhena,Mariana Millan Fachi,Allan M. Junkert,Josiane Mmf Santos,Eric Luiz Domingos,Alexandre de Fátima Cobre,Danilo Raul Ossufo Momade,Roberto Pontarolo +9 more
TL;DR: Investigation of the presence of antibiotics of different classes and associated resistant bacteria, in water samples taken from urban river waters in Curitiba, Brazil found antibiotics came from domestic effluents and may be contributing to the spread of bacterial resistance.
Journal ArticleDOI
Simultaneous determination of levodopa, carbidopa, entacapone, tolcapone, 3-O-methyldopa and dopamine in human plasma by an HPLC-MS/MS method.
Rômulo Pereira Ribeiro,João Cleverson Gasparetto,Raquel de Oliveira Vilhena,Thais Martins Guimarães de Francisco,Cleverson Antonio Ferreira Martins,Marco André Cardoso,Roberto Pontarolo,Katherine Athayde Teixeira de Carvalho +7 more
TL;DR: A HPLC-MS/MS method capable of simultaneously determining levodopa, carbidopa, entacapone, tolcapone, 3-O-methyldopa and dopamine in human plasma was developed and validated and successfully applied in plasma patients with Parkinson's disease using Stalevo®.
Journal ArticleDOI
A new HILIC-MS/MS method for the simultaneous analysis of carbidopa, levodopa, and its metabolites in human plasma.
Raquel de Oliveira Vilhena,Flávia Lada Degaut Pontes,Breno Maurício Marson,Rômulo Pereira Ribeiro,Katherine Athayde Teixeira de Carvalho,Marco André Cardoso,Roberto Pontarolo +6 more
TL;DR: The results indicated that this new method using HILIC mode and LC-MS/MS for simultaneous determination of carbidopa, levodopa, and its metabolites in human plasma is suitable for therapeutic drug monitoring in Parkinson's disease patients.
Journal ArticleDOI
Risk factors associated with delay in diagnosis and mortality in patients with COVID-19 in the city of Rio de Janeiro, Brazil
Alexandre de Fátima Cobre,Beatriz Böger,Mariana Millan Fachi,Raquel de Oliveira Vilhena,Eric Luiz Domingos,Fernanda S. Tonin,Roberto Pontarolo +6 more
TL;DR: Delays in diagnosis and risk factors for death from COVID-19 were associated with male gender, age under 60 years, and patients living in regions with lower SDI, and delays superior to eight days to diagnosis increased mortality rates.